Asset Details
Do you wish to reserve the book?
Lack of the QTc physiologic decrease during cardiac stress test in patients with type 2 diabetes treated with secretagogues
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Lack of the QTc physiologic decrease during cardiac stress test in patients with type 2 diabetes treated with secretagogues
Do you wish to request the book?
Lack of the QTc physiologic decrease during cardiac stress test in patients with type 2 diabetes treated with secretagogues
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Lack of the QTc physiologic decrease during cardiac stress test in patients with type 2 diabetes treated with secretagogues
2014
Overview
Patients with type 2 diabetes are at increased susceptibility to a prolonged QT interval. Furthermore, insulin secretagogues, drugs used to treat diabetes, may prolong QT interval and provoke arrhythmias. We evaluated whether secretagogues can affect QTc interval during cardiac stress test in 20 patients with type 2 diabetes treated with secretagogues. ECG stress test was performed in all patients. QTc interval was calculated both before cardiac stress test (BCST) and at acme of cardiac stress test (ACST). Diabetic patients treated with secretagogues showed longer QTc-ACST values than those treated with metformin only. QTc-ACST values resulted shorter than QTc-BCST values in control group. Diabetic patients treated with secretagogues showed QTc-ACST values significantly longer than QTc-BCST values. In our study, diabetic patients treated with secretagogues did not show the QTc physiologic decrease that is a protective against arrhythmias. These results suggest to evaluate, in these patients, QT length, even during routine cardiac stress test.
Publisher
Springer Milan,Springer Nature B.V
Subject
/ Arrhythmias, Cardiac - diagnosis
/ Arrhythmias, Cardiac - etiology
/ Arrhythmias, Cardiac - physiopathology
/ Carbamates - therapeutic use
/ Diabetes
/ Diabetes Mellitus, Type 2 - complications
/ Diabetes Mellitus, Type 2 - drug therapy
/ Diabetes Mellitus, Type 2 - physiopathology
/ Female
/ Humans
/ Hypoglycemic Agents - therapeutic use
/ Male
/ Medicine
